Logo image of SRTA

STRATA CRITICAL MEDICAL INC (SRTA) Stock Earnings & Estimates

USA - Nasdaq - NASDAQ:SRTA - US0926671043 - Common Stock

4.19 USD
-0.15 (-3.46%)
Last: 12/1/2025, 8:00:00 PM
4.21 USD
+0.02 (+0.48%)
After Hours: 12/1/2025, 8:00:00 PM

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
SRTA revenue by date.SRTA revenue by date.
146.1M
189.31%
225.18M
54.13%
248.693M
10.44%
213.54M
-14.14%
273.67M
28.16%
310.79M
13.56%
EBITDA
YoY % growth
SRTA ebitda by date.SRTA ebitda by date.
-44.77M
-90.51%
-40.253M
10.09%
-22.205M
44.84%
11.577M
152.14%
24.602M
112.51%
27.744M
12.77%
EBIT
YoY % growth
SRTA ebit by date.SRTA ebit by date.
-50.5M
-109.54%
-47.364M
6.21%
-28.167M
40.53%
-12.378M
56.06%
-3.295M
73.38%
-7.344M
-122.91%
Operating Margin
SRTA operating margin by date.SRTA operating margin by date.
-34.57%-21.03%-11.33%-5.80%-1.20%-2.36%
EPS
YoY % growth
SRTA eps by date.SRTA eps by date.
-0.42-0.76
-78.82%
-0.37
51.32%
-0.11
69.68%
0.02
118.18%
-0.03
-250.00%

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.01
92.15%
-0.08
-104.00%
-0.01
79.60%
0.05
202.00%
-0.03
-200.00%
Revenue
Q2Q % growth
59.16M
8.84%
61.2M
12.69%
63.24M
-10.68%
64.26M
30.35%
64.26M
8.62%
EBITDA
Q2Q % growth
6.758M
380.41%
6.426M
209.17%
7.273M
591.09%
7.864M
1,867.19%
3.06M
-54.72%
EBIT
Q2Q % growth
1.173M
114.01%
306K
104.04%
1.153M
123.27%
1.193M
121.22%
N/A

Recent Earnings VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
-0.05
-66.67%
-0.03-0.02-96.08%
Q2 2025
Q2Q % growth
-0.05
66.67%
-0.04-0.01-11.41%
Q1 2025
Q2Q % growth
-0.04
33.33%
-0.110.0764.99%
Q4 2024
Q2Q % growth
-0.13
71.11%
-0.10-0.03-24.95%
Q3 2024
Q2Q % growth
-0.03 -0.050.0238.08%
Q2 2024
Q2Q % growth
-0.15
11.76%
-0.06-0.09-145.10%
Q1 2024
Q2Q % growth
-0.06
57.14%
-0.120.0650.98%
Q4 2023
Q2Q % growth
-0.45
-109.30%
-0.13-0.32-246.02%
Q3 2023
Q2Q % growth
0.00
100.00%
-0.100.10100.00%
Q2 2023
Q2Q % growth
-0.17
-270.00%
-0.15-0.02-16.96%
Q1 2023
Q2Q % growth
-0.14
26.32%
-0.210.0734.64%
Q4 2022
Q2Q % growth
-0.22 -0.17-0.04-26.47%
Q3 2022
Q2Q % growth
-0.12
-27.88%
-0.150.0319.69%
Q2 2022
Q2Q % growth
0.10 -0.210.31148.00%
Q1 2022
Q2Q % growth
-0.19 -0.200.015.20%
SRTA Yearly EPS VS EstimatesSRTA Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 0 -0.2 -0.4 -0.6
Recent Revenue VS Estimates Surprises ()
PeriodReportedEstimateDifferenceSurprise
Q3 2025
Q2Q % growth
49.298M
-34.16%
44.88M4.418M9.84%
Q2 2025
Q2Q % growth
70.801M
4.20%
65.36M5.441M8.32%
Q1 2025
Q2Q % growth
54.306M
5.42%
50.423M3.883M7.70%
Q4 2024
Q2Q % growth
54.357M
14.49%
52.149M2.208M4.23%
Q3 2024
Q2Q % growth
74.877M
4.81%
75.934M-1.057M-1.39%
Q2 2024
Q2Q % growth
67.945M
11.40%
64.379M3.566M5.54%
Q1 2024
Q2Q % growth
51.514M
13.79%
50.451M1.063M2.11%
Q4 2023
Q2Q % growth
47.478M
24.48%
49.367M-1.889M-3.83%
Q3 2023
Q2Q % growth
71.44M
56.26%
68.281M3.159M4.63%
Q2 2023
Q2Q % growth
60.99M
71.18%
54.927M6.063M11.04%
Q1 2023
Q2Q % growth
45.27M
70.00%
41.318M3.952M9.56%
Q4 2022
Q2Q % growth
38.14M 36.427M1.713M4.70%
Q3 2022
Q2Q % growth
45.72M
125.00%
39.565M6.155M15.56%
Q2 2022
Q2Q % growth
35.63M
175.14%
28.076M7.554M26.91%
Q1 2022
Q2Q % growth
26.63M 22.094M4.536M20.53%
SRTA Yearly Revenue VS EstimatesSRTA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS57.14% N/A 0% N/A
Revenue1.13% N/A 0% N/A